Featured projects

CLLSYSTEMS: (Epi)Genomic and microenvironment interactions driving evolution in chronic lymphocytic leukemia. Targets for clinical intervention.

Principal investigator: Elías Campo Güerri.
Code: LCF/PR/HR22/52420015 (HR22-00172).

Duration: 24/07/2023 - 30/11/2025
PREGENLINF: Medicina de precisión genómica en neoplasias linfoides

Principal investigator: Elías Campo Güerri.
Funder: ISCIII .

Code: PMP21/00015.

Duration: 01/12/2022 - 30/11/2025
Genomic and microenvironment interactions driving evolution in mantle cell lymphoma (MCLSYSTEMS)

Principal investigator: Elías Campo Güerri.
Code: PID2021-123054OB-I00.

Duration: 01/09/2022 - 30/08/2025
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma

Principal investigator: Elías Campo Güerri.
Funder: National Institute of Health (NIH) ; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Institut d'Investigacions Biomèdiques August Pi i Sunyer (Sede o evento).

Code: 1P01CA229100.

Duration: 01/09/2019 - 31/08/2024
Single-cell genomics to comprehensively understand healthy B-cell maturationand transformation to chronic lymphocytic leukemia (BCLLatlas)

Principal investigator: Elías Campo Güerri.
Funder: European Commission .

Code: H2020-ERC-Sy_2018 (810287).

Duration: 01/04/2019 - 31/03/2024
CLLEvolution: Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention

Principal investigator: Elías Campo Güerri.
Funder: La Caixa Foundation .

Code: HR17-00221_ LCF/PR/HR17/52150017.

Duration: 31/12/2018 - 31/12/2022
Caracterización de la inestabilidad genómica y las mutaciones somáticas en linfoma de células del manto y su impacto pronostico

Principal investigator: Sílvia Beà Bobet.
Funder: Instituto de Salud Carlos III .

Code: PI17/01061.

Duration: 01/01/2018 - 30/06/2022
Clinical impact of tumor genomic heterogeneity and clonal evolution in B-cell lymphoid neoplasms. Establishment of new diagnostic and prognostic molecular models

Principal investigator: Elías Campo Güerri.
Funder: Ministerio de Economía y Competitividad .

Code: SAF2015-64885.

Duration: 01/06/2016 - 01/06/2018
Búsqueda de IncRNAs relacionados con la polarización de macrófagos pro-tumorogénicos (M2-TAM) en linfomas foliculares/ difusos de células grandes y evaluación de su valor clínico

Principal investigator: Luis Hernández Pous.
Funder: Instituto de Salud Carlos III .

Code: PI15/00551.

Duration: 01/01/2016 - 31/12/2018
NEW ONCOGENIC MECHANISMS OF CYCLIN D1 IN MANTLE CELL LYMPHOMA (MCL): INVOLVEMENT IN TRANSCRIPTIOANL REGULATION, DNA DAMAGE RESPONSE, AND DNA REPLICATION STRESS.

Principal investigator: Pedro Jares.
Funder: Institut D'investigacions Biomediques August Pi i Sunyer (Idibaps) (Sede o evento); Institut D'investigacions Biomediques August Pi i Sunyer (Idibaps) (Participante); Insitituto de Salud Carlos III (ISCIII) .

Duration: 01/02/2015 - 31/12/2017

The research of this group can be carried out thanks to the funders.

Featured projects

CLLSYSTEMS: (Epi)Genomic and microenvironment interactions driving evolution in chronic lymphocytic leukemia. Targets for clinical intervention.

PREGENLINF: Medicina de precisión genómica en neoplasias linfoides

Genomic and microenvironment interactions driving evolution in mantle cell lymphoma (MCLSYSTEMS)

Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma

Single-cell genomics to comprehensively understand healthy B-cell maturationand transformation to chronic lymphocytic leukemia (BCLLatlas)

CLLEvolution: Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention

Caracterización de la inestabilidad genómica y las mutaciones somáticas en linfoma de células del manto y su impacto pronostico

Clinical impact of tumor genomic heterogeneity and clonal evolution in B-cell lymphoid neoplasms. Establishment of new diagnostic and prognostic molecular models

Búsqueda de IncRNAs relacionados con la polarización de macrófagos pro-tumorogénicos (M2-TAM) en linfomas foliculares/ difusos de células grandes y evaluación de su valor clínico

NEW ONCOGENIC MECHANISMS OF CYCLIN D1 IN MANTLE CELL LYMPHOMA (MCL): INVOLVEMENT IN TRANSCRIPTIOANL REGULATION, DNA DAMAGE RESPONSE, AND DNA REPLICATION STRESS.

Major founders